| Amiodarone-induced thyroid dysfunction: a clinical update MN Elnaggar, K Jbeili, N Nik-Hussin, M Kozhippally, JM Pappachan Experimental and Clinical Endocrinology & Diabetes 126 (06), 333-341, 2018 | 43 | 2018 |
| Amiodarone-induced thyroid dysfunction: a clinical update MN Elnaggar, K Jbeili, N Nik-Hussin, M Kozhippally, JM Pappachan Experimental and Clinical Endocrinology & Diabetes 126 (06), 333-341, 2018 | 43 | 2018 |
| Primary hyperparathyroidism: findings from the retrospective evaluation of cases over a 6-year period from a regional UK centre JM Pappachan, MN Elnaggar, R Sodi, K Jbeili, PR Smith, IM Lahart Endocrine 62, 174-181, 2018 | 18 | 2018 |
| Protein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies (PCSK9mab) in Clinical Practice at Secondary Care–Real World Multicentre Experience B Bashir, S Haslam, S Ahmad, MN Elnaggar, R Allcock, S Ali, NM Kyi, ... Cureus 14 (12), 2022 | 3 | 2022 |
| The journey to LDL-C goal in the era of combination lipid lowering therapy and why it matters for ASCVD patients: a UK perspective M Elnaggar, AM Miller, A Sil, A Viljoen Current Medical Research and Opinion, 1-11, 2024 | | 2024 |
| Real world efficacy of PCSK9 inhibition for lipid lowering in diabetes B Bashir, MO Shah, S Haslam, S Ahmad, R Allcock, S Ali, L Salazar, ... DIABETIC MEDICINE 39, 2022 | | 2022 |
| Hyponatraemic seizure secondary to primary polydipsia following urological surgery J Han, J Dickinson, MN Elnaggar BMJ Case Reports CP 15 (3), e237563, 2022 | | 2022 |
| Senescence and Diabetes: a mini review NE MN Elnaggar EC Endocrinology and Metabolic research 5, 03-08, 2020 | | 2020 |
| Alpha-cells: Its Role as the Islet Harmonizer NK Elnaggar, MN Elnaggar International Journal of Diabetes and Endocrinology 12 (3), 104-107, 2019 | | 2019 |
| Correction: Amiodarone-Induced Thyroid Dysfunction: A Clinical Update MN Elnaggar, K Jbeili, N Nik-Hussin, M Kozhippally, JM Pappachan Experimental and Clinical Endocrinology & Diabetes 126 (06), e1-e1, 2018 | | 2018 |
